How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation

Featuring Benjamin Lockshin, MD | EVP of Strategic InitiativesDirector of the Clinical Trials CenterAssistant ProfessorUS Dermatology PartnersGeorgetown UniversityRockville, MD | Published July 01, 2024